Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-18

Clinical Trial Update: Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial comparing GlucoNorm with glyburide for post-prandial hyperglycemia in elderly with type 2 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GlucoNorm
  • Glyburide (glyburide)

Snippet

Sponsor: University of British Columbia | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED